Jyong Biotech Ltd. filed for an IPO that could raise as much as $40 million to advance a pipeline that includes several prospects for urinary system disorders, including one that has reached the NDA ...
AIE is a unique photophysical phenomenon, and its distinctive luminescence properties have demonstrated significant potential in the biomedical field. In urinary system diseases, AIE materials, with ...
Jyong Biotech Ltd. prices IPO at $7.50 per share, aiming to raise $20 million for drug development. Jyong Biotech Ltd., a Taiwan-based biotechnology company focused on developing plant-derived drugs ...
Urinary tract infections (UTIs) are a common health issue that affects a vast majority of the Indian population. According to the European Journal of Pharmaceutical and Medical Research, UTIs are most ...